Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection

doi:10.4254/wjh.v6.i9.652

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7119)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

300

WORD

233

HTML

2684

Figures (1-2)

151

Tables (1-3)

168

Sum=3536

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

523

Download

825

Sum=1348

Publishing Process of This Article

Item

Count

Browse

1050

Download

1185

Sum=2235

Sep 27, 2014 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Sep 27, 2014; 6(9): 652-659
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.652

Open in New Tab Full Size Figure Download Figure

Figure 1 Bubble plot of recurrence-free survival in patients receiving nucleos(t)ide analogue therapy or not after radical resection to treat hepatitis B virus-related hepatocellular carcinoma. Bubble size reflects relative cohort size. ^aP < 0.05: NA group vs Control group. NA: Nucleos(t)ide analogue.

Open in New Tab Full Size Figure Download Figure

Figure 2 Bubble plot of overall survival in patients receiving nucleos(t)ide analogue therapy or not after radical resection to treat hepatitis B virus-related hepatocellular carcinoma. Bubble size reflects relative cohort size. ^aP < 0.05: NA group vs Control group. NA: Nucleos(t)ide analogue.

Citation: Ke Y, Wang L, Li LQ, Zhong JH. Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection. World J Hepatol 2014; 6(9): 652-659
URL: https://www.wjgnet.com/1948-5182/full/v6/i9/652.htm
DOI: https://dx.doi.org/10.4254/wjh.v6.i9.652